Framework for Drug Resistance and Drug Resistance Related Issues - Fengting Yu

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

ARV-Based PrEP: Update on the Science and Scale-Up - Benjamin R. Bavinton, PhD, MPH, BA (Hon)

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

WHO Strategy for the Prevention, Monitoring, and Response to HIV Drug Resistance - Michael R. Jordan, MD, MPH

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

HIV Drug Resistance to Current New Antiretroviral Drugs - Hongxin Zhao, MD, MPH

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Challenge of Translating PEP & PrEP from Research to Practice in China - Hui Wang, MD

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Non Drug PrEP - Ishwar Gilada, MD, DDV, FCPS

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Antiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun Sun

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Toxic Side Effects of HIV ART and How to Address Them - Hongxin Zhao

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Updates on WHO HIV Treatment Guidelines - Fujie Zhang

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Scaling up Laboratory Services to Achieve the 95 95 95 - Pascale Ondoa

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Achieving 95-95-95: Implications for Asia and the Pacific Region - Eamonn Murphy

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region

Differentiated Service Delivery for HIV and Beyond - Anna Grimsrud

The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region